Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/15/2001WO2001085780A2 Nucleic acid binding polypeptides
11/15/2001WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001WO2001085778A1 A new polypeptide -human tubulin folding cofactor c13 and the polynucleotide encoding it
11/15/2001WO2001085777A2 Therapeutic pore-forming peptides
11/15/2001WO2001085775A1 A novel human hepatoma associated protein and the polynucleotide encoding said polypeptide
11/15/2001WO2001085774A1 A probiotic adhesin product, derived from lactobacillus
11/15/2001WO2001085773A2 Luxo-sigma54 interactions and methods of use
11/15/2001WO2001085772A2 Virulence genes, proteins, and their use
11/15/2001WO2001085771A1 Novel ttv-related virus s-ttv
11/15/2001WO2001085770A2 Sentinel virus ii
11/15/2001WO2001085769A2 Structure of g-protein (rgs4) and methods of identifying agonists and antagonists using same
11/15/2001WO2001085768A2 G-protein coupled receptors and uses therefor
11/15/2001WO2001085767A2 Human proteins polynucleotides encoding them and methods of using the same
11/15/2001WO2001085766A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001WO2001085765A2 Identification of mfq-110, a human c2h2-type zinc finger protein
11/15/2001WO2001085764A2 Regulation of human p2y-like g protein-coupled receptor
11/15/2001WO2001085763A2 Chimeric peptide immunogens their preparation and use
11/15/2001WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001WO2001085756A2 Site-selective acyl transfer
11/15/2001WO2001085754A1 Plant promoter
11/15/2001WO2001085752A1 A novel peptide-human myosin heavy chain 12-14 and the polynucleotide coding this novel peptide
11/15/2001WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001WO2001085210A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001WO2001085209A2 Treating t-cell mediated diseases by modulating dr6 activity
11/15/2001WO2001085208A2 Molecular antigen arrays and vaccines
11/15/2001WO2001085205A1 Compositions and methods for induction of active autoimmunity
11/15/2001WO2001085201A2 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
11/15/2001WO2001085196A2 Cxcr4 antagonist treatment of hematopoietic cells
11/15/2001WO2001085192A1 Transgenically produced decorin
11/15/2001WO2001085100A2 Vasodilator-thrombolytic fusion proteins and conjugates
11/15/2001WO2001084921A2 Transgenic animal
11/15/2001WO2001084919A1 Model systems for neurodegenerative and cardiovascular disorders
11/15/2001WO2001055172A3 ISOLATED COMPLEX COMPRISING A NNT-1 PROTEIN AND IN ADDITION AT LEAST A CLF-1 PROTEIN AND/OR A sCNTFRα PROTEIN
11/15/2001WO2001049729A8 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
11/15/2001WO2001047518A8 Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant emap ii
11/15/2001WO2001038350A3 85kDa NEISSERIAL ANTIGEN
11/15/2001WO2001036459A3 Novel use of hcc-2
11/15/2001WO2001036001A3 Interferon gamma conjugates
11/15/2001WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001WO2001030984A3 Novel halotolerant and halophilic enzymes and the use of halotolerant and halophilic enzymes
11/15/2001WO2001019974A3 Recombinant microorganisms
11/15/2001WO2001018057A3 Serine protease inhibitors (spn43a) from drosophila
11/15/2001WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001WO2001015737A3 Method for coupling molecules
11/15/2001WO2001004344A3 Induction of a th1-like response in vitro
11/15/2001WO2001003717A3 Methods of inducing cell death
11/15/2001WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001WO2000078950A3 Differentially expressed genes in the adipocytes of obese mice
11/15/2001WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001WO2000075352A3 Hcv/bvdv chimeric genomes and uses thereof
11/15/2001WO2000075298A8 Molecules for disease detection and treatment
11/15/2001WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001WO2000061636A3 Aberrantly glycosylated antibodies as marker for cancer
11/15/2001WO2000058365A9 Specific binding proteins for treating canine allergy
11/15/2001WO2000055323A9 Differential expression of organellar gene products
11/15/2001WO2000054730A3 Compositions preparations and uses of human papillomavirus l1 protein
11/15/2001WO2000047729A9 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/15/2001WO2000046369A3 Polynucleotides related to pancreatic disease
11/15/2001WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001WO2000015819A9 Packaging cell lines for hiv-derived retroviral vector particles
11/15/2001US20010042255 Nucleic acids
11/15/2001US20010041792 Extraction of growth factors from tissue
11/15/2001US20010041791 Genetic engineering
11/15/2001US20010041790 Inhibitors of formation of protease resistant prion protein
11/15/2001US20010041788 Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
11/15/2001US20010041787 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
11/15/2001US20010041680 Administering an antibody that specifically binds to EMAP(endothelial monocyte-activating polypeptides II) to the subject which needs inhibition of EMAP activity in an amount effective to stimulate vascular growth in cardiac muscle
11/15/2001US20010041679 Multiple site delivery of adenoviral vector for the induction of angiogenesis
11/15/2001US20010041670 Activity of thrombospondin (TSP-1), an antiangiogenic protein, can be modulated by stimulating or inhibiting the activity of Histidine-Rich Glycoprotein (HRGP) or a protein that includes thrombospondin binding motif of HRGP
11/15/2001US20010041669 Administering to mammal an effective amount of a hormonally inactive insulin or insulin analogue
11/15/2001US20010041362 Genetic engineering
11/15/2001US20010041361 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/15/2001US20010041355 Regulation of human nerve growth factor-related G protein-coupled receptor
11/15/2001US20010041354 Genetic engineering
11/15/2001US20010041353 Isolated nucleic acids
11/15/2001US20010041348 Animal sperm cell membrane
11/15/2001US20010041189 Dipeptide containing glutamic acid
11/15/2001US20010041183 Immediate early 63 protein; side effect reduction
11/15/2001US20010041181 Relieving pain related to muscle activity or contracture, antispasmodic
11/15/2001DE10023400A1 New acyl-carrier protein gene, acp, from coryneform bacteria, useful for increasing fermentative production of amino acids, especially lysine
11/15/2001DE10021834A1 New mRNA indicative of T cell activation and functional status, useful for diagnosis and therapy e.g. of autoimmunity or transplant rejection
11/15/2001DE10021688A1 New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
11/15/2001DE10019119A1 New leukotriene Bx receptor gene, LTBx, useful for diagnosis and treatment of LTBx-related diseases
11/15/2001CA2804977A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001CA2768046A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001CA2411244A1 Therapeutic pore-forming peptides
11/15/2001CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001CA2409505A1 Plant promoter
11/15/2001CA2409150A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001CA2408930A1 Structure of g-protein (rgs4) and methods of identifying agonists and antagonists using same
11/15/2001CA2408840A1 Myc targets
11/15/2001CA2408738A1 Virulence genes, proteins, and their use
11/15/2001CA2408732A1 Modified es cells and es cell-specific gene
11/15/2001CA2408665A1 Novel regulator of g protein signalling
11/15/2001CA2408664A1 F-box containing protein
11/15/2001CA2408652A1 A method for designing and screening random libraries of compounds
11/15/2001CA2408632A1 Ph domain-interacting protein
11/15/2001CA2408594A1 Human monoclonal antibodies to dendritic cells
1 ... 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 ... 2916